Testimony to Congress
The testimony of NIDA Director, Nora D. Volkow, M.D., and other senior staff before congress, as well as other Hearings.
A Review of the President’s Fiscal Year 2025 Budget Request for the National Institutes of Health
|
Dr. Volkow's testimony on FY 2025 NIH Budget Request
A Review of the President’s Fiscal Year 2024 Funding Request and Budget Justification for the National Institutes of Health
|
Dr. Nora Volkow, NIDA Director, and other NIH senior leaders provide NIH budget justifications at Senate LHHS appropriations hearing
A Review of the President’s FY 2023 Funding Request and Budget Justification for the National Institutes of Health
|
Dr. Nora Volkow, NIDA Director, and other NIH senior leaders provide NIH budget justifications at Senate LHHS appropriations hearing
Strengthening Federal Mental Health and Substance Use Disorder Programs: Opportunities, Challenges, and Emerging Issues
|
Chairwoman Murray, Ranking Member Burr, and members of the Committee, thank you for inviting the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH)...
The Overdose Crisis: Interagency Proposal to Combat Illicit Fentanyl-Related Substances
|
Dr. Nora Volkow testifies about the importance of advancing research on fentanyl-related substances
The Federal Responses to the Drug Overdose Epidemic
|
The twin addiction and overdose crises have collided with the COVID-19 pandemic, each exacerbating the deleterious effects of the other